ASTCT headquarters are closely monitoring the developing news about the Coronavirus (COVID-19) from the World Health Organization (WHO), Centers for Disease Control (CDC), and our community. We want you to know that we are placing the highest priority on the health and safety of all of our members and we will make decisions moving forward with the input of public health officials.

Members of ASTCT's Infectious Disease SIG have developed interim guidelines for COVID-19 management of HCT and cellular therapy patients. These guidelines will be modified as new information becomes available, including more data on epidemiology and clinical outcomes, and efficacy of drug therapies including clinical trial outcomes of novel therapeutics.

COVID-19 Interim Patient Care Guidelines

As of March 11, 2020, The ASTCT Fundamentals of HCT Pharmacy Committee has made the decision to cancel the Fundamentals of HCT course that was scheduled to occur at HOPA Ahead 2020 on Saturday, March 14 and Sunday, March 15, 2020. Details will be shared in the next 7 – 10 days on how we are planning to present this course in an alternate virtual format. This will ensure that the education that we have diligently assembled will be presented in the most impactful way possible. These details will also include information on how your registration fee will be automatically transferred to this virtual option.

As this is an evolving situation, we will keep our website updated with the latest news and information related to all of our upcoming events. Additionally, due do travel restrictions related to COVID-19, some speakers at upcoming meetings will be required to present their sessions virtually.  

If you have any questions or concerns regarding your attendance at events, you may direct them to

For additional resources, please consult the World Health Organization and the Centers For Disease Control.